Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP216701.RATsFopIBRwIIdDIpfF1iCD5xKx7iMOBmI65_dJwTI3Tw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP216701.RATsFopIBRwIIdDIpfF1iCD5xKx7iMOBmI65_dJwTI3Tw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP216701.RATsFopIBRwIIdDIpfF1iCD5xKx7iMOBmI65_dJwTI3Tw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP216701.RATsFopIBRwIIdDIpfF1iCD5xKx7iMOBmI65_dJwTI3Tw130_provenance.
- NP216701.RATsFopIBRwIIdDIpfF1iCD5xKx7iMOBmI65_dJwTI3Tw130_assertion description "[Out of glioma cell lines, 2, namely IN500 and T98G, which had elevated MRP mRNA levels, showed the highest resistance to multiple anti-cancer agents such as etoposide, vincristine and adriamycin, and decreased intracellular accumulation of etoposide.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP216701.RATsFopIBRwIIdDIpfF1iCD5xKx7iMOBmI65_dJwTI3Tw130_provenance.
- NP216701.RATsFopIBRwIIdDIpfF1iCD5xKx7iMOBmI65_dJwTI3Tw130_assertion evidence source_evidence_literature NP216701.RATsFopIBRwIIdDIpfF1iCD5xKx7iMOBmI65_dJwTI3Tw130_provenance.
- NP216701.RATsFopIBRwIIdDIpfF1iCD5xKx7iMOBmI65_dJwTI3Tw130_assertion SIO_000772 7927879 NP216701.RATsFopIBRwIIdDIpfF1iCD5xKx7iMOBmI65_dJwTI3Tw130_provenance.
- NP216701.RATsFopIBRwIIdDIpfF1iCD5xKx7iMOBmI65_dJwTI3Tw130_assertion wasDerivedFrom befree-20140225 NP216701.RATsFopIBRwIIdDIpfF1iCD5xKx7iMOBmI65_dJwTI3Tw130_provenance.
- NP216701.RATsFopIBRwIIdDIpfF1iCD5xKx7iMOBmI65_dJwTI3Tw130_assertion wasGeneratedBy ECO_0000203 NP216701.RATsFopIBRwIIdDIpfF1iCD5xKx7iMOBmI65_dJwTI3Tw130_provenance.
- befree-20140225 importedOn "2014-02-25" NP216701.RATsFopIBRwIIdDIpfF1iCD5xKx7iMOBmI65_dJwTI3Tw130_provenance.